Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Study of Chemotherapy Selection Based on Therapeutic Targets for the Treatment of Advanced Pancreatic Cancer.[Ensayo fase II de selección individualizada del tratamiento de quimioterapia en pacientes con carcinoma de páncreas avanzado en función de la determinación de dianas terapéuticas en el tejido tumoral]

Next Previous
X
Search
Trial Profile

Phase II Study of Chemotherapy Selection Based on Therapeutic Targets for the Treatment of Advanced Pancreatic Cancer.[Ensayo fase II de selección individualizada del tratamiento de quimioterapia en pacientes con carcinoma de páncreas avanzado en función de la determinación de dianas terapéuticas en el tejido tumoral]

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Antineoplastics; Capecitabine; Erlotinib; Fluorouracil; Folinic acid; Gemcitabine; Irinotecan; Oxaliplatin
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Acronyms TARGTHPANC-001

    • Most Recent Events

    • 27 Mar 2012 Biomarkers information updated
    • 17 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
    • 17 Mar 2012 Actual initiation date (Aug 2011) added as reported by European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top